COVID-19: US FDA expands Pfizer booster, opens extra dose to age 16

On Thursday, the FDA gave emergency authorization for 16- and 17-year-olds to get a third dose made by Pfizer and its partner BioNTech -- if it's been six months since their last shot.

from Lifestyle News:Entertainment News,Bollywood Latest News,Box Office Collection Report,Movie Reviews
Read The Rest:financialexpress...